Diffusing capacity for carbon monoxide is linked to ventilatory demand in patients with chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 1, 2012, Pages 16-21

  Mahut, Bruno ^a   Chevalier Bidaud, Brigitte ^a   Plantier, Laurent ^a,b   Essalhi, Mohamed ^a   Callens, Etienne ^a   Graba, Semia ^a   Gillet Juvin, Karine ^a   Valcke Brossollet, Judith ^a   Delclaux, Christophe ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Dyspnea; Exercise test; Physiological dead space

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MALE; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; TIDAL VOLUME; VENTILATORY DEMAND;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GAS MONITORING, TRANSCUTANEOUS; CARBON DIOXIDE; CROSS-SECTIONAL STUDIES; DYSPNEA; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL EXERTION; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY DEAD SPACE; TIDAL VOLUME;

EID: 84856591719     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.630700     Document Type: Article

References (31)

1. Anonymous. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999 Jan; 159(1):321-340.
2. de Torres JP, Casanova C, Montejo de Garcini A, et al. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease. Respir Res 2007; (8):18.
3. O'Donnell DE, Webb KA. Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest 1992 Sep; 102(3):824-831.
4. Bafadhel M, Umar I, Gupta S, et al. The role of computed tomography in multi-dimensional phenotyping of chronic obstructive pulmonary disease. Chest 2011 Mar 31; Epub ahead of print.
5. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med 2008 Mar; 102(3):367-376.
6. Delclaux C, Chevalier-Bidaud B, Essalhi M, et al. Too rapid increase and too much breathlessness are distinct indices of exertional dyspnea in COPD. Respir Physiol Neurobiol 2011 Jan 22; Epub ahead of print.
7. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007 Sep 15; 176(6):532-555. (Pubitemid 47403272)
8. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005 Aug; 26(2):319-338. (Pubitemid 41079078)
9. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct; 26(4):720-735. (Pubitemid 41448672)
10. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005 Sep; 26(3):511-522. (Pubitemid 41264217)
11. Anonymous. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003 Jan 15; 167(2):211-277.
12. Callens E, Graba S, Gillet-Juvin K, et al. Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 2009 Dec; 136(6):1466-1472.
13. Borg E, Kaijser L. A comparison between three rating scales for perceived exertion and two different work tests. Scand J Med Sci Sports 2006 Feb; 16(1):57-69. (Pubitemid 43433306)
14. Gandevia B, Hugh-Jones P. Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax 1957 Dec; 12(4):290-293.
15. Hubert D, Aubourg F, Fauroux B, et al. Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments. Eur Respir J 2009 Jul; 34(1):117-124.
16. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 Mar; 16:5-40.
17. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008 Feb 1; 177(3):253-260. (Pubitemid 351198367)
18. Wasserman K, Hansen JE, Sue DY, et al. Normal values. Principles of exercice testing and interpretation. Including pathophysiology and clinical applications. Fourth edition. Philadelphia-Baltimore-New York-London-Buenos Aires- Hong Kong-Sydney-Tokyo: L. W. Wilkins; c2005; 160-182.
19. Hamilton AL, Killian KJ, Summers E, et al. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996 Nov; 110(5):1255-1263. (Pubitemid 26380482)
20. Dornhorst AC. Respiratory insufficiency. Lancet 1955 Jun 11; 268(6876):1185-1187.
21. Sahebjami H, Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000 Mar; 161(3 Pt 1):886-890. (Pubitemid 30171747)
22. Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 2009 Jun; 106(6):1902-1908.
23. Barbera JA, Riverola A, Roca J, et al. Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994 Feb; 149(2 Pt 1):423-429. (Pubitemid 24068990)
24. Sandek K, Bratel T, Lagerstrand L, et al. Relationship between lung function, ventilation-perfusion inequality and extent of emphysema as assessed by high-resolution computed tomography. Respir Med 2002 Nov; 96(11):934-943. (Pubitemid 35243642)
25. Steinacker JM, Liu Y. Transcutaneous pCO2-monitoring during exercise is valid! Int J Sports Med 1994 Nov; 15(8):525-526.
26. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007 May; 4(2):145-168. (Pubitemid 46743309)
27. O'Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009 May 30; 167(1):116-132.
28. Blanco I, Gimeno E, Munoz PA, et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010 Feb 1; 181(3):270-278.
29. Humbert M, Simonneau G. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time! Am J Respir Crit Care Med 2010 Feb 1; 181(3):202-203.
30. Peinado VI, Pizarro S, Barbera JA. Pulmonary vascular involvement in COPD. Chest 2008 Oct; 134(4):808-814.
31. Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 Mar 15; 177(6):622-629. (Pubitemid 351442169)